Skip to content

Analysis of apolipoprotein A2 isoform as a novel pancreatic exocrine marker

Analysis of apolipoprotein A2 isoform as a novel pancreatic exocrine marker - Analysis of apolipoprotein A2 isoform as a novel pancreatic exocrine marker

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028150
Enrollment
200
Registered
2017-07-10
Start date
2017-07-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers, patients with chronic pancreatitis, patients with chronic hepatitis

Interventions

Blood test and PFD test

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Healthy volunteers: 1) Volunteers who are 20 years old or older and under 75 years old when registering. Gender is male. 2) No history of pancreatic disease. 3) Currently not receiving internal treatment. 4) Consent is obtained in writing on participation of this research. 2.Patients with chronic pancreatitis: Patients who underwent a PFD test with reasons for insurance indication (suspected decline in pancreatic exocrine function). The age, sex does not matter. 3.fat-water MRI: Patient who took fat-water MRI with reasons for insurance indication (chronic liver disease). The age, sex does not matter.

Exclusion criteria

Exclusion criteria: 1.Normal Volunteers: Exclusion criteria are as follows. 1: Cases where pancreatic diseases are merged. 2: In case of internal medication treatment. In the case of 3: Example of impaired renal function. 4: Example of acute hepatitis. 5: Case of alcohol sensitivity. 2.Patients with chronic pancreatitis: There is no special exclusion criteria. 3.fat - water MRI: Exclusion criteria are not specifically provided.

Design outcomes

Primary

MeasureTime frame
Presence or absence of correlation between Pancreatic Functioning Diagnostant (PFD) test result which is a pancreatic exocrine function test and apolipoprotein A2 isoform,

Secondary

MeasureTime frame
Presence or absence of correlation between pancreatic fat percentage and apolipoprotein A2 isoform

Countries

Japan

Contacts

Public ContactShingo Kato

Yokohama City University School of Medicine, Yokohama, Japan Department of Gastroenterology and Hepatology

shin800m@yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026